97-11921. Manufacturer of Controlled Substances; Notice of Application  

  • [Federal Register Volume 62, Number 89 (Thursday, May 8, 1997)]
    [Notices]
    [Pages 25209-25210]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-11921]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Drug Enforcement Administration
    
    
    Manufacturer of Controlled Substances; Notice of Application
    
        Pursuant to Section 1301.43(a) of Title 21 of the code of Federal 
    Regulations (CFR), this is notice that on December 18, 1996, Johnson 
    Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, 
    West Deptford, NJ 08066, made application by renewal to the Drug 
    Enforcement Administration (DEA) for registration as a bulk 
    manufacturer of the basic classes of controlled substances listed 
    below:
    
    ------------------------------------------------------------------------
                        Drug                               Schedule         
    ------------------------------------------------------------------------
    Difenoxin (9168)............................  I                         
    Methylphenidate (1724)......................  II                        
    Dihydrocodeine (9120).......................  II                        
    Oxycodone (9143)............................  II                        
    Hydromorphone (9150)........................  II                        
    Hydrocodone (9193)..........................  II                        
    Levorphanol (9220)..........................  II                        
    Meperidine (9230)...........................  II                        
    Methadone (9250)............................  II                        
    Thebaine (9333).............................  II                        
    
    [[Page 25210]]
    
                                                                            
    Alfentanil (9737)...........................  II                        
    Sufentanil (9740)...........................  II                        
    Carfentanil (9743)..........................  II                        
    Fentanyl (9801).............................  II                        
    ------------------------------------------------------------------------
    
        The firm plans to manufacture the listed controlled substances in 
    bulk to supply final dosage form manufacturers.
        Any other such applicant and any person who is presently registered 
    with DEA to manufacture such substances may file comments or objections 
    to the issuance of the above application.
        Any such comments or objections may be addressed, in quintuplicate, 
    to the Acting Deputy Assistant Administrator, Office of Diversion 
    Control, Drug Enforcement Administration, United States Department of 
    Justice, Washington, DC 20537, Attention: DEA Federal Register 
    Representative (CCR), and must be filed no later than July 7, 1997.
    
        Dated: March 31, 1997.
    Terrance W. Woodworth,
    Acting Deputy Assistant Administrator, Office of Diversion Control, 
    Drug Enforcement Administration.
    [FR Doc. 97-11921 Filed 5-7-97; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
05/08/1997
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
97-11921
Pages:
25209-25210 (2 pages)
PDF File:
97-11921.pdf